RA Medical Systems Inc (NYSE:RMED) Q1 2020 Earnings Conference Call - Final Transcript

May 13, 2020 • 04:30 pm ET


RA Medical Systems Inc (NYSE:RMED) Q1 2020 Earnings Conference Call - Final Transcript


Loading Event

Loading Transcript


Ladies and gentlemen, thank you for standing by. Welcome to the Ra Medical Systems first quarter 2020 conference call. As a reminder, this call is being recorded today, May 13, 2020. After the speaker's presentation there will be a question-and-answer session. [Operator Instructions]

I'd now like to turn the call over to Jody Cain. Please go ahead.

Jody Cain

This is Jody Cain with LHA. Thank you for participating in today's call. Joining me from Ra Medical are Will McGuire, Chief Executive Officer and Andrew Jackson, Chief Financial Officer. Earlier today, Ra Medical issued a news release announcing financial results for the first quarter of 2020. If you've not received this news release or you'd like to be added to the company's email distribution list, please contact LHA in Los Angeles at (310) 691-7100 and speak with Kasha Chen. The news release is also available on the Investor Relations section of the Ra Medical website.

During this call, management will be making a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. To the extant that statements made by management are not descriptions of historical facts regarding Ra Medical. They are forward-looking statements reflecting the beliefs and expectations of management as of May 13th, 2020. You should not place undue reliance on these forward-looking statements because they involve known and unknown risks, uncertainties and other factors that are in some cases beyond the company's control, and could materially affect actual results. In particular, there is significant uncertainty about the duration and contemplation impact of COVID-19 pandemic. This means results could change at any time in the contemplated impact of COVID-19 on Ra medicals operations.

Financial results and outlook is a best estimate based on the information for today's discussion. For details about these risks, please see the earnings release that accompanies this call and the company's SEC filings, including Ra medicals annual report on Form 10-K for the year ended December 31, 2019, filed with the SEC on March 11, 2020, and quarterly report on Form 10-Q for the period ended 31st, 2020, to be filed with the SEC. Ra Medical expressly disclaims any intent or obligation to update forward-looking statements except as required by law.

Today's conference call remarks will include both GAAP and non-GAAP financial results. Ra Medical believes the non-GAAP financial results provide investors with useful supplemental information about the financial performance of the business, enables the comparison of financial results between periods for certain items may vary independently of business performance and allow for greater transparency with respect to key metrics used by management in operating the business. These non-GAAP financial measures are presented solely for informational and comparative purposes. It should not be regarded as a replacement for corresponding GAAP measures. Reconciliation between GAAP and non-GAAP financial measures can be found at the end of the financial results news release that was issued earlier today.

With that I'd like to turn the call over to Will McGuire. Will?

Will McGuire

Thanks, Jody. Good